Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati).

× No keyword cloud information.

14 in total

1. Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium.

Authors: P J Sansonetti; J Arondel; J R Cantey; M C Prévost; M Huerre
Journal: Infect Immun Date: 1996-07 Impact factor: 3.441

Review 2. Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors: Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal: Nat Rev Microbiol Date: 2007-07 Impact factor: 60.633

3. Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.

Authors: S R Klee; B D Tzschaschel; I Fält; A Kärnell; A A Lindberg; K N Timmis; C A Guzmán
Journal: Infect Immun Date: 1997-06 Impact factor: 3.441

4. An update on vaccines against Shigella.

Authors: Shai Ashkenazi; Dani Cohen
Journal: Ther Adv Vaccines Date: 2013-09

5. Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

Authors: K L Kotloff; D A Herrington; T L Hale; J W Newland; L Van De Verg; J P Cogan; P J Snoy; J C Sadoff; S B Formal; M M Levine
Journal: Infect Immun Date: 1992-06 Impact factor: 3.441

6. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.

Authors: K L Kotloff; F Noriega; G A Losonsky; M B Sztein; S S Wasserman; J P Nataro; M M Levine
Journal: Infect Immun Date: 1996-11 Impact factor: 3.441

7. Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model.

Authors: A B Hartman; M M Venkatesan
Journal: Infect Immun Date: 1998-09 Impact factor: 3.441

8. Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains.

Authors: A B Hartman; C J Powell; C L Schultz; E V Oaks; K H Eckels
Journal: Infect Immun Date: 1991-11 Impact factor: 3.441

9. Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.

Authors: E V Oaks; T L Hale; S B Formal
Journal: Infect Immun Date: 1986-07 Impact factor: 3.441

10. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.

Authors: N Orr; G Robin; D Cohen; R Arnon; G H Lowell
Journal: Infect Immun Date: 1993-06 Impact factor: 3.441